US$ 24.39
glp 1 receptor agonist drugs Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 Receptor Agonists as Treatments
Description
Sign up for our newsletterStay ahead of development by receiving our newsletter on the latest sector knowledge.E-mail addressClearContinueI want to receive customized email newsletters from Watch Medier A/S, including information about our brands and group companies, conferences, courses, networking, competitions and digital services."n"nWith my consent, I also agree to the processing of my personal data and that information about my interaction with marketing messages (such as opening and reading) is collected using tracking pixels and similar technologies

Diabetes Metab Syndr 19(2):103185 Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis

Thus, shared decision-making between surgical, anesthetic, and medical teams is essential to balance risks and benefits [111]

Another large clinical trial by the same team (LEADER) reported similar results, with a higher incidence of retinal lesions in participants receiving subcutaneous liraglutide compared to the placebo group, though this difference was not statistically significant

2023;151(2):e2022060640
